Literature DB >> 17210754

Interleukin-1beta and inducible form of nitric oxide synthase expression in early syngeneic islet transplantation.

Marta Montolio1, Montse Biarnés, Noèlia Téllez, Jessica Escoriza, Joan Soler, Eduard Montanya.   

Abstract

Islets are particularly vulnerable in the initial days after transplantation when cell death results in the loss of more than half of the transplanted islet tissue. To determine whether a non-specific inflammation at the grafted site mediated by the local expression of inflammatory cytokines could play a role on the initial damage to transplanted islets, we studied the expressions of interleukin-1beta (IL-1beta) and inducible form of nitric oxide synthase (iNOS) after syngeneic islet transplantation. Insulin-treated streptozotocin-diabetic Lewis rats were syngeneically transplanted with 500 islets. Grafts were harvested 1, 3, or 7 days after transplantation, and the expressions of IL-1beta and iNOS genes were determined by RT-PCR. IL-1beta and iNOS mRNAs were detected in islets immediately after isolation, and were upregulated after transplantation. IL-1beta mRNA was ninefold increased on day 1, was still sevenfold increased on day 3 after transplantation, and declined towards pretransplantation levels on day 7. iNOS mRNA showed a similar pattern of expression to that of IL-1beta: on days 1 and 3 after transplantation it was 14-and 4-fold higher respectively than in freshly isolated islets. In addition, IL-1beta and iNOS were identified in islet grafts and found to be produced mainly by CD68-positive macrophages. A low number of IL-1beta- and iNOS-positive but CD68-negative cells were also identified suggesting that other cell types, in addition to macrophages, were involved in the expression of IL-1beta and NO production in islet grafts. The finding of increased IL-1beta and iNOS gene expressions in the initial days after islet transplantation and the presence of IL-beta and iNOS proteins in the graft confirmed the presence of an early non-specific inflammatory response after islet transplantation. Overall, the data suggest that IL-1beta plays a role in the extensive beta-cell death found in the initial days after islet transplantation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17210754     DOI: 10.1677/joe.1.06968

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  23 in total

1.  Adenoviral overproduction of interleukin-1 receptor antagonist increases beta cell replication and mass in syngeneically transplanted islets, and improves metabolic outcome.

Authors:  N Téllez; M Montolio; E Estil-les; J Escoriza; J Soler; E Montanya
Journal:  Diabetologia       Date:  2007-01-13       Impact factor: 10.122

Review 2.  Challenges and emerging technologies in the immunoisolation of cells and tissues.

Authors:  John T Wilson; Elliot L Chaikof
Journal:  Adv Drug Deliv Rev       Date:  2007-10-11       Impact factor: 15.470

3.  Donor Pretreatment With IL-1 Receptor Antagonist Attenuates Inflammation and Improves Functional Potency in Islets From Brain-Dead Nonhuman Primates.

Authors:  Juan S Danobeitia; Matthew S Hanson; Peter Chlebeck; Elisa Park; Jamie M Sperger; Alice Schwarznau; Luis A Fernandez
Journal:  Cell Transplant       Date:  2014-04-22       Impact factor: 4.064

Review 4.  Survival of encapsulated islets: More than a membrane story.

Authors:  Uriel Barkai; Avi Rotem; Paul de Vos
Journal:  World J Transplant       Date:  2016-03-24

5.  Monocyte-Derived Dendritic Cells Impair Early Graft Function Following Allogeneic Islet Transplantation.

Authors:  Kevin V Chow; Emma M Carrington; Yifan Zhan; Andrew M Lew; Robyn M Sutherland
Journal:  Cell Transplant       Date:  2016-10-13       Impact factor: 4.064

6.  Inducible nitric-oxide synthase and nitric oxide donor decrease insulin receptor substrate-2 protein expression by promoting proteasome-dependent degradation in pancreatic beta-cells: involvement of glycogen synthase kinase-3beta.

Authors:  Toshihiro Tanioka; Yoshiaki Tamura; Makiko Fukaya; Shohei Shinozaki; Ji Mao; Minhye Kim; Nobuyuki Shimizu; Tadahiro Kitamura; Masao Kaneki
Journal:  J Biol Chem       Date:  2011-06-23       Impact factor: 5.157

Review 7.  Progress and challenges in macroencapsulation approaches for type 1 diabetes (T1D) treatment: Cells, biomaterials, and devices.

Authors:  Shang Song; Shuvo Roy
Journal:  Biotechnol Bioeng       Date:  2016-01-04       Impact factor: 4.530

8.  Thrombosis and inflammation in intraportal islet transplantation: a review of pathophysiology and emerging therapeutics.

Authors:  John T Wilson; Elliot L Chaikof
Journal:  J Diabetes Sci Technol       Date:  2008-09

9.  Inhibition of c-jun N terminal kinase (JNK) improves functional beta cell mass in human islets and leads to AKT and glycogen synthase kinase-3 (GSK-3) phosphorylation.

Authors:  A Fornoni; A Pileggi; R D Molano; N Y Sanabria; T Tejada; J Gonzalez-Quintana; H Ichii; L Inverardi; C Ricordi; R L Pastori
Journal:  Diabetologia       Date:  2007-12-08       Impact factor: 10.122

10.  Interferon regulatory factor-1 is a key transcription factor in murine beta cells under immune attack.

Authors:  C Gysemans; H Callewaert; F Moore; M Nelson-Holte; L Overbergh; D L Eizirik; C Mathieu
Journal:  Diabetologia       Date:  2009-09-08       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.